Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

China flag China · Delayed Price · Currency is CNY
111.91
-5.15 (-4.40%)
Sep 17, 2025, 3:09 PM CST
-4.40%
Market Cap17.82B
Revenue (ttm)432.14M
Net Income (ttm)-186.95M
Shares Out159.27M
EPS (ttm)-1.17
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume13,507,774
Average Volume16,565,686
Open114.10
Previous Close117.06
Day's Range111.55 - 117.76
52-Week Range17.70 - 188.93
Beta1.24
RSI45.10
Earnings DateAug 28, 2025

About SHE:300436

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers drugs for anti-HBV, anti-infection, liver diseases, metabolism and digestive system, respiratory, cardiovascular, men’s health, and other fields. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzhou, China. [Read more]

Sector Healthcare
Founded 2001
Employees 760
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300436
Full Company Profile

Financial Performance

In 2024, SHE:300436's revenue was 441.46 million, an increase of 4.43% compared to the previous year's 422.71 million. Losses were -156.30 million, -55.16% less than in 2023.

Financial Statements

News

There is no news available yet.